Concepedia
Statistics
Publications
8
Citations
2.5K
H-Index
Active since
1998
Affiliations
University of Edinburgh(Current)
Roslin Institute
University of Cambridge
University of Oxford
King's College London
Meg Hibbert is an author at University of Edinburgh specializing in pharmacotherapy, 28-day mortality, and primary outcome analysis.
Publications per year
1998–2024
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 564 citations · Full text
Pharmacy, Infectious Diseases, Pharmacotherapy +6
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 521 citations · Full text
Pharmacy, Internal Medicine, Pharmacotherapy +11
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 384 citations · Full text
Life Sciences, Immunology, Pharmacotherapy +14
Whole-genome sequencing reveals host factors underlying critical COVID-19
Athanasios Kousathanas, Erola Pairo‐Castineira, Konrad Rawlik et al. · Nature · 2022 · 347 citations · Full text
Life Sciences, Infectious Diseases, Molecular Genetics +17
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 291 citations · Full text
Pharmacy, Internal Medicine, Pharmacotherapy +13
1–5 of 8